Merck HIV Discount Plan Sets DuPont Sustiva Price Floor At $500 Per Year
Merck is setting the lowest global price for DuPont's non-nucleoside reverse transcriptase inhibitor Stocrin/Sustiva at a 17% discount to the lowest price for Crixivan.
Merck is setting the lowest global price for DuPont's non-nucleoside reverse transcriptase inhibitor Stocrin/Sustiva at a 17% discount to the lowest price for Crixivan.